Gilead Sciences (GILD)

$66.76 0.60 (0.91%)

16:00 EDT GILD Stock Quote Delayed 30 Minutes

3 Biotech Stocks That Could Skyrocket in the Next 12 Months

By Muslim Farooque, InvestorPlace Contributor Jun 7, 2023

These promising biotech stocks are risky but offer tremendous upside generating stellar long-term returns in the upcoming 12 months.

3 Undervalued Biotech Stocks to Buy Before They Blast Off

3 Analyst Upgrades That Smart Investors Won’t Ignore

GILD Stock Price Predictions: Is Gilead Sciences Really Worth $100?

Volume:

Previous Close -

Market Cap 83.70B

PE Ratio 14.87

EPS 4.49

Volume (Avg. Vol.) 10.66M

Day's Range $66.16 - $66.83

52-Week Range $65.90 - $87.86

Dividend & Yield $3.00 (4.49%)

GILD Stock Predictions, Articles, and Gilead Sciences News

From InvestorPlace
From the Web

3 Cash-Rich Biotech Stocks to Bet on for the Long Haul

By John Blankenhorn, InvestorPlace Contributor Apr 25, 2023

Cash rich biotech stocks can survive while most of their peers struggle with rising interest rates. Here are three to watch.

Strong Quant Screens Say These 7 Growth Stocks Are a Buy

By Chris Lau, InvestorPlace Contributor Apr 19, 2023

Stockrover’s quant screen is a grading system that brings up rewarding growth stocks to buy for income investors.

7 Cash-Rich Companies to Invest in During Economic Uncertainty

By Josh Enomoto, InvestorPlace Contributor Feb 26, 2023

Although they’re not necessarily the most exciting enterprises, these cash-rich stocks should keep your portfolio upright.

7 Dividend Stocks to Buy and Hold Forever

By Will Ashworth, InvestorPlace Contributor Dec 21, 2022

If you’re a dividend investor these seven dividend stocks to buy and hold forever are worth considering heading into 2023.

Gilead Sciences (GILD) Stock Falls on Lung Cancer Drug Data

By Josh Enomoto, InvestorPlace Contributor Dec 20, 2022

Although Gilead Sciences produced meaningful results regarding a lung cancer drug test, the competitive shortfall hurt GILD stock.

The 7 Best Retirement Stocks to Buy Now

By Louis Navellier and the InvestorPlace Research Staff Dec 18, 2022

Current bear market conditions present the perfect opportunity to invest in retirement stocks while they're trading at bargain valuations.

Why Is Arcellx (ACLX) Stock Up 25% Today?

By David Moadel, InvestorPlace Contributor Dec 9, 2022

ACLX stock is usually under the radar, but today it's in the spotlight as Arcellx reveals a team-up with a well-known biotech business.

7 Monthly Dividend Stocks to Buy for Safety

By Muslim Farooque, InvestorPlace Contributor Sep 29, 2022

These safe monthly dividend stocks offer investors incredible dividend yields and healthy upside potential

Why Is Gilead Sciences (GILD) Stock Up Today?

By Bret Kenwell, InvestorPlace Contributor Sep 12, 2022

Gilead Sciences has a low valuation, but no growth. Perhaps settling a patent lawsuit will help give GILD stock the boost it needs.

What Is Going on With Gilead Sciences (GILD) Stock Today?

By David Moadel, InvestorPlace Contributor Aug 16, 2022

GILD stock is the focus of not just one but two news items today, and traders are trying to decide if they're bullish or bearish.

7 Growth Stocks to Buy After a 20% Correction

By Tezcan Gecgil, InvestorPlace Contributor Aug 15, 2022

These are among the best growth stocks to buy now. ADBE, AMD, GILD, LOW, MELI, MP, and PYPL are poised to benefit from strong trends in 2022.

7 Best Pharmaceutical Stocks to Buy Now

By Muslim Farooque, InvestorPlace Contributor Jul 20, 2022

These investments represent the best pharmaceutical stocks. Each offers incredible upside potential in the post-pandemic world.

7 Biotech Stocks With Key Catalysts Coming in July

By Tezcan Gecgil, InvestorPlace Contributor Jun 27, 2022

Biotech stocks have suffered significant setbacks during the first half of the year but are likely to bounce back soon

7 Oversold Stocks to Buy Right Now

By Tezcan Gecgil, InvestorPlace Contributor Jun 8, 2022

Identifying oversold stocks gives investors the opportunity to buy shares that they perhaps already liked, only at a discounted price.

7 Safe Dividend Stocks With High Yields to Buy Now

By Chris Markoch, InvestorPlace Contributor May 31, 2022

Investors are seeking dividend stocks. Here are seven safe dividend stocks that offer a high yield to maximize their total return.

7 Dividend Stocks Paying Over 5% to Buy Now

By Chris Lau, InvestorPlace Contributor Apr 26, 2022

Stock markets will return less this year as interest rates rise and cause a recession, so investors should demand higher yield.

The 7 Highest Dividend Stocks for Income Investors

By Louis Navellier and the InvestorPlace Research Staff Feb 9, 2022

These dividend stocks, including SCCO stock and CQP stock, offer high yields, a proven track record and high ratings in Dividend Grader.

5 Biotech Stocks to Buy to Benefit From Biden’s New Cancer Cabinet

By Samuel O'Brient, InvestorPlace Reporter Feb 4, 2022

Joe Biden is redoubling his efforts to fight cancer with a new "cancer cabinet." Here are the biotech stocks to buy that can benefit.

7 Safe Stocks for Your Retirement

By Louis Navellier and the InvestorPlace Research Staff Jan 7, 2022

In a dynamic market like the one we're in now, it's important to buy safe stocks that will build your nest egg in the years to come.

7 Pharmaceutical Stocks That Could Make You Rich

By Tezcan Gecgil, InvestorPlace Contributor Jan 6, 2022

These seven pharmaceutical stocks could create lucrative opportunities in the new year

Gilead Sciences (GILD)

3 Biotech Stocks That Could Skyrocket in the Next 12 Months

3 Undervalued Biotech Stocks to Buy Before They Blast Off

3 Analyst Upgrades That Smart Investors Won’t Ignore

GILD Stock Price Predictions: Is Gilead Sciences Really Worth $100?

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Gilead Sciences (GILD)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

GILD Stock Predictions, Articles, and Gilead Sciences News

Subscriber Sign in